S. Hescot

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study

S. Hescot, María Currás-Freixes, Timo Deutschbein et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 176 citations · Full text

French Endocrine Society Guidance on endocrine side effects of immunotherapy

Frédéric Castinetti, F. Albarel, F. Archambeaud et al. · Endocrine Related Cancer · 2018 · 139 citations · Full text

Oncology, Endocrine-related Cancer, Icpi Withdrawal +15

One-Year Progression-Free Survival of Therapy-Naive Patients With Malignant Pheochromocytoma and Paraganglioma

S. Hescot, Sophie Leboulleux, Laurence Amar et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 117 citations · Full text

Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells

S. Hescot, Abdelhamid Slama, Anne Lombès et al. · Endocrine Related Cancer · 2013 · 96 citations · Full text

Comparative Analysis of Durable Responses on Immune Checkpoint Inhibitors Versus Other Systemic Therapies: A Pooled Analysis of Phase III Trials

Elvire Pons‐Tostivint, Aurélien Latouche, Pauline Vaflard et al. · JCO Precision Oncology · 2019 · 95 citations